New HIV vaccine trial starts at University of Oxford

A new HIV vaccine trial is under way at University of Oxford. Picture: David Cheskin/PA

Researchers at the University of Oxford have started a clinical trial for a novel HIV vaccine candidate.

The goal of the trial, known as HIV-Core 0052, is to evaluate the safety, tolerability, and immunogenicity of the HIVconsvX vaccine.